High Throughput Illucidx Covid-19 RT-LAMP

  • Utilizes Reverse Transcription (RT), Isothermal Loop-mediated Amplification (LAMP) Nucleic acid Test

  • Utilize nasopharyngeal (NP) swabs to determine the presence SARS-Cov-2 genetic material (RNA) in patients with signs of Covid-19 Symptoms. 

  • Intended for trained clinical laboratory personnel trained in molecular techniques of RT-LAMP, nucleic acid extraction and in vitro diagnostic procedures. 

  • Clinically validating and seeking Health Canada and FDA emergency use authorization. 

  • Clinical validation data demonstrates that the level of detection using our primer sets approaches that of currently deployed qPCR based tests. 

Please see the Instruction For Use (IFU) document for further details and validation data. This diagnostic has been clinically validated and Health Canada and FDA's independent review of this validation is pending. 

Near-Patient Platform Illucidx Covid-19 Saliva LAMP

  • Utilizes Isothermal Loop-mediated Amplification (LAMP) Nucleic acid test and Visual Detection.

  • Point-of-care diagnostic platform utilizing off the shelf hardware.

  • Low cost, Rapid, Sensitive and Specific detection.

  • 15 min Extraction and 45 min Amplification.

  • Health Canada Interim Order Submission Pending. 

  • Can be performed in EMS and in remote locations 

Please see the Instruction For Use (IFU) document for further details and validation data. This diagnostic has been clinically validated and Health Canada and FDA's independent review of this validation is pending. 

Coming Soon: Cartridge Based Diagnostic Testing

 
  • Simple point of care solution for results in less than an hour

  • Extremely portable

  • Increased Reproducibility

  • Minimal labour and infrastructure cost

  • Simple easy to use hardware

  • Decreased risk of contamination   

For support, more details, or requests please contact us now: 

TM​

TM​

LogoMakr-0D12bz-300dpi_edited.png

Headquartered in Calgary, Alberta, Canada we hope to enable broad access to ultra-sensitive diagnostics tools for settings across the globe. Our first priority is, and will always remain, to improve clinical outcomes.

Please email for direct number

 

3655 36 St NW 

Calgary, AB T2L 1Y8

Canada

  • LinkedIn

© 2020 Illucidx Inc Previously Elucidx Inc.